Steven H. Bernstein

Steven H. Bernstein

Chief Tech/Sci/R&D Officer bij 2SEVENTY BIO, INC.

Health Technology
Consumer Services
Health Services

Profiel

Steven H.
Bernstein
is currently the Chief Medical Officer at 2seventy Bio, Inc. He previously worked as the Chairman of Immuno-Oncology Translational Research at Bristol Myers Squibb Co., a Professor of Medicine and Co-Director of Hematological at James P.
Wilmot Cancer Center, a Member of Lymphoma Working Group at SWOG, and the Chief Translational Officer at Turnstone Biologics Corp.
He received his undergraduate degree from Brandeis University and his doctorate from New York University School of Medicine.

Actieve functies van Steven H. Bernstein

BedrijvenFunctieBegin
2SEVENTY BIO, INC. Chief Tech/Sci/R&D Officer 14-02-2022
Alle actieve functies van Steven H. Bernstein

Eerdere bekende functies van Steven H. Bernstein

BedrijvenFunctieEinde
Corporate Officer/Principal -
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal -
James P. Wilmot Cancer Center Corporate Officer/Principal -
TURNSTONE BIOLOGICS CORP. Chief Tech/Sci/R&D Officer -
Ervaring van Steven H. Bernstein in detail bekijken

Opleiding van Steven H. Bernstein

Brandeis University Undergraduate Degree
New York University School of Medicine Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Steven H. Bernstein in detail bekijken

Connecties

15

Eerstegraads connecties

7

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven3
BRISTOL-MYERS SQUIBB COMPANY

Health Technology

TURNSTONE BIOLOGICS CORP.

Health Technology

2SEVENTY BIO, INC.

Health Technology

Bedrijven in privébezit2
James P. Wilmot Cancer Center

Health Services

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Steven H. Bernstein